Zacks Investment Research on MSN
NTRA debuts Zenith Genomics next-gen sequencing test for rare diseases
Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to ...
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has ...
BASEL, Switzerland--(BUSINESS WIRE)--Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement with MGI Tech and Complete Genomics, USA, ...
Aberdeen Proving Ground, MD – Future battlefields require an on-the-go approach to the identification of whatever biological threat our warfighters may come across. One such approach – Far-Forward ...
Her computations allow physicians to more quickly diagnose and treat life-threatening genetic diseases. Sneha Goenka is one of MIT Technology Review’s 2025 Innovators Under 35. Meet the rest of this ...
With a new generation of fast and affordable gene sequencers, researchers are better equipped than ever to tackle Earth’s most pressing ecological challenges Sometimes, when the wind blows in the ...
Goal to combine Ultima’s highly sensitive, low-cost technology with Quest’s oncology expertise and national scale in order to improve patient access, affordability and outcomes The collaboration aims ...
What is Third-Generation Sequencing? Third-generation sequencing, also known as long-read sequencing, refers to the latest advancements in DNA sequencing technologies that enable the analysis of ...
Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune response, ...
Identifying low-abundance monoclonal antibodies within a population of polyclonal antibodies provides insights for various applications, including understanding disease mechanisms, vaccine development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results